KKR to invest in Arbor Pharmaceuticals
KKR is to acquire a significant minority stake Arbor Pharmaceuticals. Financial terms of the transaction have not been disclosed. Acquired by its current investor group in 2010, Arbor markets branded prescription products for the cardiovascular, hospital, and paediatric markets as well as generic products through its Wilshire division. The company